Chronic Urticaria in the Real-Life Clinical Practice Setting in Portugal: Baseline Results from the Non-Interventional Multicentre AWARE Study.
暂无分享,去创建一个
C. Costa | J. Ferreira | A. R. Martins | C. Brito | J. Marques | F. Azevedo | J. Antunes | G. M. Pinto | G. Velho | V. Sousa | A. Piña | I. Raposo | A. Massa | S. Prates | A. P. Cunha | A. Guilherme | I. Rosmaninho | J. Sousa
[1] T. Zuberbier,et al. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria , 2018, Allergy.
[2] C. Vestergaard,et al. Chronic urticaria in the real‐life clinical practice setting in Sweden, Norway and Denmark: baseline results from the non‐interventional multicentre AWARE study , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.
[3] T. Jakob,et al. H1‐antihistamine‐refractory chronic spontaneous urticaria: it's worse than we thought – first results of the multicenter real‐life AWARE study , 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[4] C. Costa,et al. [Diagnostic and Therapeutic Approach of Chronic Spontaneous Urticaria: Recommendations in Portugal]. , 2016, Acta medica portuguesa.
[5] M. Maurer,et al. Effect of omalizumab on angioedema in H1‐antihistamine‐resistant chronic spontaneous urticaria patients: results from X‐ACT, a randomized controlled trial , 2016, Allergy.
[6] S. Thomsen,et al. Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria: evaluation of 154 patients , 2016, The British journal of dermatology.
[7] A. Knulst,et al. Healthcare Resource Utilisation Among Chronic Spontaneous/Idiopathic Urticaria Patients- Findings From The First International Burden of Illness Study (Assure-Csu). , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[8] J. Vietri,et al. Effect of chronic urticaria on US patients: analysis of the National Health and Wellness Survey. , 2015, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[9] M. Maurer,et al. Systematic review of treatments for chronic spontaneous urticaria with inadequate response to licensed first‐line treatments , 2015, International journal of dermatology.
[10] S. Savic,et al. Retrospective case note review of chronic spontaneous urticaria outcomes and adverse effects in patients treated with omalizumab or ciclosporin in UK secondary care , 2015, Allergy, Asthma & Clinical Immunology.
[11] M. Broder,et al. Resource Use and Costs in an Insured Population of Patients with Chronic Idiopathic/Spontaneous Urticaria , 2015, American Journal of Clinical Dermatology.
[12] Michihiro Hide,et al. The EAACI/GA 2 LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update , 2015 .
[13] H. Kurzen,et al. Chronic spontaneous urticaria – a management pathway for patients with chronic spontaneous urticaria , 2015, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[14] J. Bartra,et al. Management of urticaria: not too complicated, not too simple , 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[15] William H. Yang,et al. Insights and advances in chronic urticaria: a Canadian perspective , 2015, Allergy, Asthma & Clinical Immunology.
[16] S. Till,et al. BSACI guideline for the management of chronic urticaria and angioedema , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[17] S. Spector,et al. Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study. , 2015, The Journal of investigative dermatology.
[18] C. Feighery,et al. Allergy in Irish adults: a survey of referrals and outcomes at a major centre , 2015, Irish Journal of Medical Science (1971 -).
[19] T. Zuberbier,et al. Measuring patient severity in chronic spontaneous/idiopathic urticaria (CSU/CIU) as categorical health states: efficient and informative? , 2014 .
[20] T. Zuberbier,et al. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. , 2014, Allergy.
[21] J. Sheikh,et al. The diagnosis and management of acute and chronic urticaria: 2014 update. , 2014, The Journal of allergy and clinical immunology.
[22] J. Hébert,et al. Real-life experiences with omalizumab for the treatment of chronic urticaria. , 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[23] M. Maurer,et al. Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis. , 2014, Journal of dermatological science.
[24] J. Bartra,et al. Assessment of severity and quality of life in chronic urticaria. , 2014, Journal of investigational allergology & clinical immunology.
[25] T. Zuberbier,et al. Revisions to the international guidelines on the diagnosis and therapy of chronic urticaria , 2013, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[26] P. Kuna,et al. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. , 2013, The Journal of allergy and clinical immunology.
[27] T. Casale,et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. , 2013, The New England journal of medicine.
[28] M. Maurer,et al. Selected urticaria patients benefit from a referral to tertiary care centres – results of an expert survey , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.
[29] S. Frischbutter,et al. Pharmacology of Antihistamines , 2011, Indian journal of dermatology.
[30] E. Kocaturk,et al. Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: A real life survey , 2012, The Journal of dermatology.
[31] S. Mathur,et al. The role of autoimmune testing in chronic idiopathic urticaria. , 2012, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[32] Y. Ye,et al. Effects of Omalizumab Treatment in Patients With Refractory Chronic Urticaria , 2012, Allergy, asthma & immunology research.
[33] M. Broder,et al. Cost, utilization, and patterns of medication use associated with chronic idiopathic urticaria. , 2012, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[34] T. Zuberbier. Pharmacological rationale for the treatment of chronic urticaria with second‐generation non‐sedating antihistamines at higher‐than‐standard doses , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.
[35] David M Lang,et al. Utility of routine laboratory testing in management of chronic urticaria/angioedema. , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[36] H. Miot,et al. Quality of life in chronic urticaria: a survey at a public university outpatient clinic, Botucatu (Brazil). , 2011, Revista da Associacao Medica Brasileira.
[37] K. Brockow,et al. H1-Antihistamine Up-Dosing in Chronic Spontaneous Urticaria: Patients' Perspective of Effectiveness and Side Effects – A Retrospective Survey Study , 2011, PloS one.
[38] A. Barbosa,et al. Chronic idiopathic urticaria and anxiety symptoms , 2011, Journal of health psychology.
[39] M. Akiyama,et al. Prevalence of dermatological disorders in Japan: A nationwide, cross‐sectional, seasonal, multicenter, hospital‐based study , 2011, The Journal of dermatology.
[40] J. Bousquet,et al. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report 1 , 2011, Allergy.
[41] T. Zuberbier,et al. Epidemiology of urticaria: a representative cross‐sectional population survey , 2010, Clinical and experimental dermatology.
[42] J. Sheikh,et al. A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria. , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[43] Hei Sung Kim,et al. The impact of chronic idiopathic urticaria on quality of life in korean patients. , 2009, Annals of dermatology.
[44] T. Zuberbier,et al. Chronic urticaria: a patient survey on quality‐of‐life, treatment usage and doctor–patient relation , 2009, Allergy.
[45] T. Zuberbier,et al. Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients , 2009, The British journal of dermatology.
[46] A. Kaplan. What the first 10,000 patients with chronic urticaria have taught me: a personal journey. , 2009, The Journal of allergy and clinical immunology.
[47] M. Ferrer. Epidemiology, healthcare, resources, use and clinical features of different types of urticaria. Alergológica 2005. , 2009, Journal of investigational allergology & clinical immunology.
[48] T. Zuberbier,et al. How to assess disease activity in patients with chronic urticaria? , 2008, Allergy.
[49] B. Engin,et al. Prospective randomized non‐blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.
[50] Suephy C. Chen,et al. Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients. , 2008, Archives of dermatology.
[51] C. Grattan,et al. Guidelines for evaluation and management of urticaria in adults and children , 2007, The British journal of dermatology.
[52] A. Kaplan. Clinical practice. Chronic urticaria and angioedema. , 2002, The New England journal of medicine.
[53] A. Finlay,et al. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use , 1994, Clinical and experimental dermatology.
[54] A. Nardacci. Urticaria: evaluation and treatment. , 1986, Comprehensive therapy.